Ruqayyah Snyder
Huntington's disease (HD) is a rare neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia. The prevalence of the disease varies across the world, with a higher prevalence among Caucasian populations than in Asian populations. In Australia, it is estimated that around 2,160 people have an HD diagnosis, with Tasmania having the highest prevalence of 12.1 cases per 100,000 people. The median age of onset is 41 years old, and the median survival rate is 18.8 years. While there have been studies examining the risk factors and prevalence of HD in Australia, more research is needed to fully understand the incidence and impact of the disease in the country.
| Characteristics | Values |
|---|---|
| Number of people with HD in Australia | 2,160 (estimate) |
| Prevalence in Australia | 5.7 per 100,000 (Caucasian populations) |
| Prevalence in Tasmania | 12.1 per 100,000 |
| Median age of onset | 41 years old |
| Median admission age | 48 years old |
| Median survival | 18.8 years |
| Risk of death | 5.9x increased risk compared to the general population |
Explore related products
What You'll Learn
- The prevalence of Huntington's disease in Australia is estimated at 5.7 per 100,000 people
- Tasmania has the highest prevalence of HD in Australia, with 12.1 cases per 100,000 people
- The median age of onset for HD patients in Australia is 41 years old
- HD is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia
- There is currently no cure for Huntington's disease
The prevalence of Huntington's disease in Australia is estimated at 5.7 per 100,000 people
The prevalence of Huntington's disease is estimated at 5.7 per 100,000 people in Australia. This estimate is based on a meta-analysis of 13 studies, 11 of which were conducted in Europe, North America, and Australia, with an overall prevalence of 5.70 per 100,000 people. This prevalence rate is higher than the worldwide service-based prevalence of 2.71 per 100,000 people.
Huntington's disease (HD) is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia. It is an autosomal-dominant disorder, which means that if one parent carries the gene, their children have a 50% chance of inheriting it. The prevalence of HD varies across different regions of Australia, with Tasmania having the highest prevalence at 12.1 cases per 100,000 people. This unusually high prevalence in Tasmania has prompted researchers to conduct various studies on the region's HD population.
The Australian government has recognised the need to support individuals affected by HD and has developed a large and supportive HD community spread throughout the continent. Australia's first nationwide registry, Map-HD, aims to map people living with HD to improve care and services. It is estimated that around 2,160 Australians have an HD diagnosis, and the prevalence is expected to increase modestly over time due to improved diagnostic tools and increased recognition of the disease.
The impact of HD extends beyond those with the diagnosis, as it affects their families and caregivers as well. The Australian Huntington's Disease Association provides support to Tasmanians affected by HD, offering financial and moral support, special equipment, food supplements, and information resources. The association also facilitates connections between individuals and families affected by HD, fostering a sense of community and mutual support.
While the prevalence of HD in Australia is estimated at 5.7 per 100,000 people, it is important to note that this estimate may not fully capture the impact of the disease. The HDNA prevalence study aims to address this by determining the number of people in Australia with HD or at risk of developing it, providing a more comprehensive understanding of the disease's prevalence and impact on the population.
Australia's Favorite Postpaid Phone Carrier
You may want to see also
Explore related products
Tasmania has the highest prevalence of HD in Australia, with 12.1 cases per 100,000 people
Huntington's disease (HD) is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia. It is a polyglutamine disease caused by a CAG trinucleotide repeat expansion in the huntingtin gene (HTT), located on chromosome 4. The prevalence of HD varies across the world, with a higher prevalence among Caucasian populations than in Asian populations.
In Australia, the prevalence of HD is estimated to be around 5.7 per 100,000 people. However, in Tasmania, an island state off the southern coast of Australia, the prevalence is significantly higher, with 12.1 cases per 100,000 people. This makes Tasmania the region within Australia with the highest prevalence of HD. The unusually high prevalence in Tasmania has prompted researchers to conduct various studies on the region's HD population, making it a well-studied area in the context of global HD.
The high prevalence of HD in Tasmania may be due to historical factors. In 1949, Dr Charles Brothers encountered a large Tasmanian family presenting symptoms of HD. This family, known as "the Brothers family" in research literature, has continued to be studied over the years. It is believed that HD was first brought to Tasmania in 1842 by an English woman named Mary, who inherited the disease from her father, Robert.
The Huntington's Disease Association provides support for Tasmanians affected by HD, offering financial and moral support, special equipment, food supplements, and information booklets. The association also helps connect people affected by HD with one another, fostering a sense of community and support.
While Tasmania has the highest prevalence of HD in Australia, it is important to note that the overall prevalence of HD in the country is relatively low, with an estimated 2,160 Australians diagnosed with the disease. However, this number may not capture the full scope of HD in Australia, as there has not been a comprehensive study on the prevalence of the disease in the country.
Understanding Weekend Work: Australia's Saturday Penalty Rates
You may want to see also
Explore related products
The median age of onset for HD patients in Australia is 41 years old
Australia has an estimated HD prevalence of 5.7 per 100,000 people, which is higher than the worldwide average of 2.71 per 100,000. Tasmania, an island state off the southern coast of Australia, has the highest prevalence of HD in the country, with 12.1 cases per 100,000 people. This unusually high prevalence has prompted researchers to conduct various studies on the region's HD population.
Huntington's disease (HD) is a rare neurodegenerative disorder characterised by chorea, behavioural and psychiatric manifestations, and dementia. It is an autosomal-dominant disorder, meaning that a person only needs to inherit one copy of the defective gene from either parent to be affected. The disease is caused by a CAG trinucleotide repeat expansion in the huntingtin gene (HTT) located on chromosome 4.
The Map-HD Registry, an initiative of the Huntington's Disease Network of Australia (HDNA), is Australia's first nationwide registry to map people living with HD. The registry aims to map participants' locations, obstacles in accessing HD clinical care, community services, and experiences with Commonwealth-supported disability insurance entitlements. It is estimated that around 2,160 Australians have an HD diagnosis, and these individuals can now register with the Map-HD Registry to better support and connect with others affected by HD.
Sky News Australia: Popularity and Influence
You may want to see also
Explore related products
$62.97 $74.95
$35.92 $39.95
$99.95 $109.9
HD is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia
Huntington's disease (HD) is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia. It is caused by a dominantly inherited gene mutation that can be passed down from generation to generation. However, very rarely, an individual can develop HD with no known family history of the disorder. These situations are thought to be due to spontaneous mutations. The disease typically begins in mid-adulthood, between the ages of 30 and 55. However, juvenile-onset HD (JHD) occurs in about 10% of cases and is nearly always inherited from a father with the HD gene mutation.
The earliest symptoms of HD are often subtle problems with mood or mental/psychiatric abilities, followed by more obvious motor symptoms. The characteristic physical symptoms of HD include jerky, random, and uncontrollable movements called chorea. These movements may begin as uncontrolled movements of the extremities, face, or trunk, and they become more progressive and apparent as the disease advances. In addition to the movement disorder, HD also results in behavioural and personality changes and cognitive decline (dementia).
The basal ganglia region of the brain is gradually damaged in HD, leading to a loss of medium spiny neurons and astrogliosis. Brain imaging studies such as computed tomography (CT) and magnetic resonance imaging (MRI) may show atrophy of the affected parts of the brain, especially the caudate nuclei and putamen (parts of the basal ganglia). Structural MRI studies have found atrophy of the caudate, nucleus accumbens, putamen, and globus pallidus to be correlated with decreased functional capacity in individuals with manifest HD.
The prevalence of HD varies across different populations. In Australia, North America, and Western Europe, the prevalence is higher than in Asian populations. The overall prevalence in Caucasian populations is estimated to be 5.7 per 100,000, while in Asian populations, it is 0.40 per 100,000. In Australia specifically, it is estimated that around 2,160 people have an HD diagnosis.
Ben & Jerry's: Australian-Made or Imported?
You may want to see also
Explore related products
There is currently no cure for Huntington's disease
Huntington's disease (HD) is a rare, neurodegenerative disorder characterised by chorea, behavioural manifestations, and dementia. It is a genetic brain disorder, and if a parent has Huntington's disease, their child has a 50% chance of developing it. The age of onset varies, but most people develop it in their 30s or 40s. In rare cases, children or adolescents will develop the disease, and their symptoms are often similar to Parkinson's disease.
In Australia, it is estimated that around 2,160 people have an HD diagnosis. This is based on a prevalence of 5.7 per 100,000, which is consistent across North America and Western Europe. In contrast, the prevalence in Asia is much lower, at 0.40 per 100,000.
While there is currently no cure, there are numerous clinical trials underway investigating new ways to treat Huntington's disease. These trials are targeting the disease from numerous different angles, and experts believe that ongoing research may one day result in a cure. For example, a recently concluded trial found that a once-a-day medication, valbenazine, improved chorea symptoms in Huntington's disease patients and is currently awaiting FDA approval.
Exploring Australia: P&O's Fleet Size and Offerings
You may want to see also
Frequently asked questions
It is estimated that around 2,160 Australians have an HD diagnosis. However, the prevalence varies across the continent, with Tasmania having the highest prevalence of 12.1 cases per 100,000 people.
Huntington's disease (HD) is a rare neurodegenerative disorder characterized by chorea, behavioral manifestations, and dementia. It is an autosomal-dominant disorder caused by a CAG trinucleotide repeat expansion in the huntingtin gene (HTT) on chromosome 4.
The prevalence of HD in Australia is higher than in Asian countries, with an overall prevalence of 5.7 per 100,000 in Australia compared to 0.40 per 100,000 in Asia.
